MedMira Inc. (MIR.V)
CAD 0.08
(-5.88%)
CAD 0.08
(-5.88%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 9.25 Million CAD | 12.01% |
| 2022 | 8.26 Million CAD | -40.27% |
| 2021 | 13.83 Million CAD | 20.25% |
| 2020 | 11.5 Million CAD | 35.06% |
| 2019 | 8.52 Million CAD | 12.37% |
| 2018 | 7.58 Million CAD | 11.8% |
| 2017 | 6.78 Million CAD | 9.35% |
| 2016 | 6.2 Million CAD | -7.32% |
| 2015 | 6.69 Million CAD | 10.48% |
| 2014 | 6.05 Million CAD | -11.6% |
| 2013 | 6.85 Million CAD | 37.18% |
| 2012 | 4.99 Million CAD | -63.34% |
| 2011 | 13.62 Million CAD | 6.84% |
| 2010 | 12.75 Million CAD | 8.79% |
| 2009 | 11.72 Million CAD | 9.44% |
| 2008 | 10.71 Million CAD | 4.74% |
| 2007 | 10.22 Million CAD | 8.41% |
| 2006 | 9.43 Million CAD | 15.91% |
| 2005 | 8.13 Million CAD | 75.65% |
| 2004 | 4.63 Million CAD | 179.43% |
| 2003 | 1.65 Million CAD | -80.38% |
| 2002 | 8.45 Million CAD | 58983.77% |
| 2001 | -14.35 Thousand CAD | -100.12% |
| 2000 | 11.97 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 8.07 Million CAD | -3.51% |
| 2024 Q1 | 8.36 Million CAD | -9.63% |
| 2024 Q3 | 5.94 Million CAD | -26.4% |
| 2023 Q2 | 8.75 Million CAD | 1.69% |
| 2023 FY | 9.25 Million CAD | 12.01% |
| 2023 Q1 | 8.61 Million CAD | 4.21% |
| 2023 Q4 | 9.25 Million CAD | 0.22% |
| 2023 Q3 | 9.23 Million CAD | 5.47% |
| 2022 Q2 | 7.46 Million CAD | -28.97% |
| 2022 Q4 | 8.26 Million CAD | 3.87% |
| 2022 Q1 | 10.5 Million CAD | -24.08% |
| 2022 FY | 8.26 Million CAD | -40.27% |
| 2022 Q3 | 7.95 Million CAD | 6.63% |
| 2021 Q1 | 11.22 Million CAD | -2.46% |
| 2021 Q2 | 11.6 Million CAD | 3.4% |
| 2021 FY | 13.83 Million CAD | 20.25% |
| 2021 Q3 | 11.5 Million CAD | -0.86% |
| 2021 Q4 | 13.83 Million CAD | 20.26% |
| 2020 Q1 | 13.83 Million CAD | 62.33% |
| 2020 Q2 | 11.66 Million CAD | -15.67% |
| 2020 Q3 | 11.53 Million CAD | -1.1% |
| 2020 Q4 | 11.5 Million CAD | -0.24% |
| 2020 FY | 11.5 Million CAD | 35.06% |
| 2019 FY | 8.52 Million CAD | 12.37% |
| 2019 Q4 | 8.52 Million CAD | 3.3% |
| 2019 Q3 | 8.24 Million CAD | 0.61% |
| 2019 Q2 | 8.19 Million CAD | 2.75% |
| 2019 Q1 | 7.97 Million CAD | 5.22% |
| 2018 Q4 | 7.58 Million CAD | 0.59% |
| 2018 FY | 7.58 Million CAD | 11.8% |
| 2018 Q1 | 7.2 Million CAD | 6.15% |
| 2018 Q2 | 7.38 Million CAD | 2.55% |
| 2018 Q3 | 7.53 Million CAD | 2.1% |
| 2017 Q4 | 6.78 Million CAD | 3.59% |
| 2017 Q2 | 6.12 Million CAD | 0.47% |
| 2017 Q1 | 6.09 Million CAD | -1.72% |
| 2017 Q3 | 6.54 Million CAD | 6.89% |
| 2017 FY | 6.78 Million CAD | 9.35% |
| 2016 Q4 | 6.2 Million CAD | 7.64% |
| 2016 FY | 6.2 Million CAD | -7.32% |
| 2016 Q3 | 5.76 Million CAD | 27.6% |
| 2016 Q2 | 4.51 Million CAD | 36.46% |
| 2016 Q1 | 3.3 Million CAD | -50.55% |
| 2015 FY | 6.69 Million CAD | 10.48% |
| 2015 Q3 | 6.01 Million CAD | -7.52% |
| 2015 Q4 | 6.69 Million CAD | 11.26% |
| 2015 Q1 | 5.88 Million CAD | -2.87% |
| 2015 Q2 | 6.5 Million CAD | 10.55% |
| 2014 Q4 | 6.05 Million CAD | 10.19% |
| 2014 Q1 | 1.77 Million CAD | -74.05% |
| 2014 FY | 6.05 Million CAD | -11.6% |
| 2014 Q2 | 3.68 Million CAD | 107.38% |
| 2014 Q3 | 5.49 Million CAD | 49.06% |
| 2013 Q3 | 6.26 Million CAD | 11.56% |
| 2013 Q1 | 6.52 Million CAD | 30.51% |
| 2013 FY | 6.85 Million CAD | 37.18% |
| 2013 Q4 | 6.85 Million CAD | 9.37% |
| 2013 Q2 | 5.61 Million CAD | -13.85% |
| 2012 Q1 | 14.47 Million CAD | 6.23% |
| 2012 Q3 | 17.01 Million CAD | -0.29% |
| 2012 FY | 4.99 Million CAD | -63.34% |
| 2012 Q4 | 4.99 Million CAD | -70.64% |
| 2012 Q2 | 17.06 Million CAD | 17.9% |
| 2011 Q2 | 14.56 Million CAD | 9.55% |
| 2011 Q1 | 13.29 Million CAD | 4.22% |
| 2011 Q3 | 14.71 Million CAD | 1.05% |
| 2011 Q4 | 13.62 Million CAD | -7.4% |
| 2011 FY | 13.62 Million CAD | 6.84% |
| 2010 FY | 12.75 Million CAD | 8.79% |
| 2010 Q1 | 6.8 Million CAD | -42.0% |
| 2010 Q2 | 9.07 Million CAD | 33.47% |
| 2010 Q3 | 11.91 Million CAD | 31.24% |
| 2010 Q4 | 12.75 Million CAD | 7.07% |
| 2009 Q1 | 11.22 Million CAD | 4.81% |
| 2009 Q2 | 12.16 Million CAD | 8.33% |
| 2009 Q3 | 11.87 Million CAD | -2.4% |
| 2009 Q4 | 11.72 Million CAD | -1.25% |
| 2009 FY | 11.72 Million CAD | 9.44% |
| 2008 Q1 | 9.74 Million CAD | -4.71% |
| 2008 FY | 10.71 Million CAD | 4.74% |
| 2008 Q4 | 10.71 Million CAD | 7.05% |
| 2008 Q3 | 10 Million CAD | -2.12% |
| 2008 Q2 | 10.22 Million CAD | 4.91% |
| 2007 FY | 10.22 Million CAD | 8.41% |
| 2007 Q1 | 21.84 Million CAD | 131.49% |
| 2007 Q3 | 10.56 Million CAD | 0.06% |
| 2007 Q4 | 10.22 Million CAD | -3.23% |
| 2007 Q2 | 10.56 Million CAD | -51.64% |
| 2006 FY | 9.43 Million CAD | 15.91% |
| 2006 Q4 | 9.43 Million CAD | 14.21% |
| 2006 Q3 | 8.26 Million CAD | -25.86% |
| 2006 Q1 | 10.59 Million CAD | 30.17% |
| 2006 Q2 | 11.14 Million CAD | 5.16% |
| 2005 Q4 | 8.13 Million CAD | 15.45% |
| 2005 FY | 8.13 Million CAD | 75.65% |
| 2005 Q1 | 6.27 Million CAD | 35.48% |
| 2005 Q2 | 6.67 Million CAD | 6.37% |
| 2005 Q3 | 7.05 Million CAD | 5.56% |
| 2004 Q1 | 1.97 Million CAD | 19.3% |
| 2004 FY | 4.63 Million CAD | 179.43% |
| 2004 Q3 | 3.33 Million CAD | 47.43% |
| 2004 Q4 | 4.63 Million CAD | 38.94% |
| 2004 Q2 | 2.26 Million CAD | 14.35% |
| 2003 Q3 | 9.44 Million CAD | 6.78% |
| 2003 Q1 | 9.06 Million CAD | 7.29% |
| 2003 FY | 1.65 Million CAD | -80.38% |
| 2003 Q2 | 8.84 Million CAD | -2.5% |
| 2003 Q4 | 1.65 Million CAD | -82.43% |
| 2002 Q3 | 1.37 Million CAD | 86.43% |
| 2002 FY | 8.45 Million CAD | 58983.77% |
| 2002 Q2 | 735.27 Thousand CAD | 137.8% |
| 2002 Q4 | 8.45 Million CAD | 516.5% |
| 2002 Q1 | 309.19 Thousand CAD | 0.0% |
| 2001 FY | -14.35 Thousand CAD | -100.12% |
| 2000 FY | 11.97 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Arch Biopartners Inc. | 4.18 Million CAD | -121.224% |
| Covalon Technologies Ltd. | -7.23 Million CAD | 228.011% |
| Hemostemix Inc. | 4.16 Million CAD | -122.223% |
| Universal Ibogaine Inc. | 1.01 Million CAD | -815.163% |
| Kane Biotech Inc. | 7.52 Million CAD | -23.002% |
| Marvel Biosciences Corp. | 443.37 Thousand CAD | -1988.066% |
| NervGen Pharma Corp. | -11.46 Million CAD | 180.769% |
| XORTX Therapeutics Inc. | -4.53 Million CAD | 304.33% |